Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease

Clinical trial NCT02847052 · COMPLETED

Trial details

NCT number: NCT02847052
Sponsor: Nantes University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Disease

Start date: 2014-08-01
Primary completion: 2022-03-16
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.